Clavaseptin 50 mg Palatable Tablets for Dogs and Cats

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: VMD (Veterinary Medicines Directorate)

العنصر النشط:

Amoxicillin, Clavulanic Acid

متاح من:

Vetoquinol UK Ltd

ATC رمز:

QJ01CR02

INN (الاسم الدولي):

Amoxicillin, Clavulanic Acid

الشكل الصيدلاني:

Tablet

نوع الوصفة الطبية :

POM-V - Prescription Only Medicine – Veterinarian

المجموعة العلاجية:

Cats, Dogs

المجال العلاجي:

Antimicrobial

الوضع إذن:

Authorized

تاريخ الترخيص:

2004-06-18

خصائص المنتج

Revised: February 2020
AN: 00191/2019
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Clavaseptin 50 mg Palatable tablets for dogs and cats
Amoxicillin/Clavulanic acid
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
Active substances:
Amoxicillin (as amoxicillin
trihydrate)……………….……………..……….40 mg
Clavulanic acid (as potassium
salt)……………………………………......10 mg
Excipients
Brown iron oxide
(E172)………………………………….…..…….….. 0,095
mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Beige scored tablet that can be divided into two equal parts.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs and cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In dogs: treatment or adjunctive treatment of periodontal infections
caused by bacteria
susceptible
to
amoxicillin
in
combination
with
clavulanic
acid
i.e.
_Pasteurella _
spp,
_Streptococcus_ spp and _Escherichia coli_.
In cats: treatment of skin infections (including wounds and abscesses)
caused by bacteria
susceptible
to
amoxicillin
in
combination
with
clavulanic
acid
i.e.
_Pasteurella _
spp,
_Staphylococcus _spp, _Streptococcus _spp and _Escherichia coli_.
Revised: February 2020
AN: 00191/2019
Page 2 of 7
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to penicillins or other
substances of the β-lactam
group or to any of the excipients.
Do not administer to gerbils, guinea pigs, hamsters, rabbits and
chinchillas.
Do not administer to horses and ruminating animals.
Do not use in animals with serious dysfunction of the kidneys
accompanied by anuria or
oliguria.
Do not use in cases of known resistance to the combination of
amoxicillin and clavulanic
acid.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
In animals with impaired liver and kidney function, the use of the
product should be subject
to a risk/benefit